Best Practices in Supplier-Provider Collaboration Initiative

This initiative, selected by SMI Members, this team is identifying and exploring the best practices, both in healthcare and in other industries, that create, maintain, and grow successful supplier-provider collaboartions. This new Initiative Team is first sharing knowledge and insights on collaboration creation and will begin to unlock the potential of supplier-provider alliances by identifying the value propositions for both trading partners.  Team members will conduct pilots to measure alliances that positively impact cost, quality and outcomes. This team will provide the industry with a best practice toolkit with education, insights and templates, as well as case-study examples with value propositions and barriers. SMI Members interested in participating in this initiative should contact Christine Dean for more information.

Future Best Practices in Value Analysis Initiative

Under the leadership of Mary Beth Lang of UPMC, this SMI Initiative Team has focused their efforts on exploring new models for value analysis programs that will meet the needs of the industry’s future. In many current cases, it is believed that the application and organization of value analysis programs in healthcare do not optimally support healthcare’s transition to producing quality patient outcomes. It is the hope of this team that value analysis in the future will be a recognized, understood, data-driven, evidence based, collaborative process that engages the appropriate stakeholders, including suppliers, in the review, analysis, and decision making about the many contributing factors, including supplies and devices, that contribute to  quality patient care.  . The work of this Team is expected to continue through the Fall of 2013 and new Initiative Team members are welcome.  SMI Members interested in joining this Team should contact Dennis Orthman.  

Low Cost Trading Partner Initiative

Lowering the high cost of SG&A in healthcare supply chain has been identified as an area that SMI and its members can positively influence.  SMI staff and members are currently in the planning stages of this project to determine the project mission, approaches, and educational requirements of Initiative team participants. This Initiative is expected to be officially launched at the SMI Spring 2013 Forum. SMI Members interested in participating in this initiative should contact Dennis Orthman for more information.

UDI Compliance Initiative

In early 2014, SMI embarked upon a special initiative entitled the UDI Compliance Initiative. Working in response to a request by the FDA, and in collaboration with Duke Health and the Duke Clinical Research Institute, a team of SMI Members is evaluating four UDI labeling strategies for non-sterile implantable products. The non-sterile implantable products - primarily implantable devices and the associated implantable products like screws and plates – present a particular set of challenges for unique device identification, as labeling is hindered by their size, the challenge of re-processing, and the nature of the supply chain that serves surgery. An SMI Initiative Team has been formed that includes implantable device manufacturers, providers from Duke Health, and new SMI Collaborators AORN and IAHCSMM. The Team’s objective is to simulate surgery with Duke surgical professionals at the Duke simulation laboratories, collecting and documenting user feedback on each labeling strategy and assessing the ability of each strategy to support provider capture of the UDI information. A complete summary report of this Team’s work is expected to be released before July 2015.  SMI Members interested in learning more about this initiative should contact Dennis Orthman for more information.

Untitled Document